Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
about
Cytotoxic CD4 T cells in antiviral immunityDual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinomaEBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2Adoptive T-Cell ImmunotherapyUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsPotential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusAutophagy in the regulation of pathogen replication and adaptive immunityAdoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceInterference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma HerpesvirusesExpansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donorsEpstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosisImmunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyType 2 polarized immune response holds a major position in Epstein-Barr virus-related idiopathic thrombocytopenic purpura (EBV-ITP).Virus and autoantigen-specific CD4+ T cells are key effectors in a SCID mouse model of EBV-associated post-transplant lymphoproliferative disordersNuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosisDendritic cells during Epstein Barr virus infection.CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.Antigen processing for MHC presentation by autophagy.Immune escape of γ-herpesviruses from adaptive immunityPersistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.EBV-associated lymphomas in adultsCytolytic T lymphocytes from HLA-B8+ donors frequently recognize the Hodgkin's lymphoma associated latent membrane protein 2 of Epstein Barr virus.Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.Contributions of humoral and cellular immunity to vaccine-induced protection in humans.Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCsTreatment options for post-transplant lymphoproliferative disorder and other Epstein-Barr virus-associated malignancies.The initiation and prevention of multiple sclerosis.Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target.Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cellsEBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.Epstein-barr virus: environmental trigger of multiple sclerosis?Antigen Processing for MHC Class II Presentation via Autophagy.Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific AntigensEBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in functionEvidence of an oncogenic gammaherpesvirus in domestic dogs.
P2860
Q21296742-C4157206-5323-45C1-8C0E-885263678C50Q24610485-6814F152-B310-47DE-8FBB-0055EADDEC5DQ24657388-89AF0AAB-4DAB-4991-B03C-22580C979C85Q26782845-C7FA0D07-A90C-4F25-AA04-2CC2FF2A5F19Q26823898-93A0CDCB-E9BC-42EE-812E-2E4136163075Q26852071-F7C96481-3CE0-4385-9076-2C63D0ECA59FQ27023949-F0E5DF7D-9ED8-4164-8778-5DD2014205DAQ27324235-F2BE5C69-E290-40FA-A9C1-1C9376E37725Q28080898-1C3D8D5A-F983-4EB2-BC9E-E0F5D4EC5CC1Q28362584-E8961F5F-75F8-43A5-A592-27D34C3F904BQ28362603-DE8EA763-79D7-4A39-AF20-63B866DCD15EQ28731829-54B00126-FF50-45B8-9BD3-676C1FCB36C2Q33289956-B806F901-9807-4460-9B02-C8A9CFB552C7Q33397364-693C23DF-11E6-49A2-A411-1B620C3F88E9Q33650689-C56630F8-40B9-42B7-8F69-E139F9DB18ECQ33719767-8B5C87E3-A605-4CF1-9301-B2D49681DD0FQ33764503-12A538BD-CE1A-4BA7-A6F0-0B97E2E08B35Q33782152-40B22000-4917-4D66-8FFC-4BFF4D10ADADQ33851257-BCBFC469-D9D8-4E37-9D93-0E62273F90FFQ34275895-EE9752F8-54CC-459B-92B7-4158BE199BB1Q34343395-5C3C5A4A-AAF3-4FFC-85C6-5476A5FB7377Q34345549-A2F9EE19-8A81-4862-82C8-B4926D9EBBDAQ34602196-51C3A358-0B0C-4885-9521-0A3F0B5A4059Q34622755-074D497E-EC94-4C61-BB44-4BBBF9CD2199Q34636601-BD908B7A-79C5-41B0-B7C3-79D0FAD2BE32Q34712758-2907A3B6-C138-47FB-9AB8-0BD17A850774Q35018043-D48A6343-628A-46E7-B50B-87865FA1241DQ35615024-1C3E2C4D-A40E-4CE2-9C01-1CE8862173CDQ35616090-9150C439-4EC3-42F7-9053-31BD9C268F2FQ35645903-041A8334-33D3-42C5-8916-0BD811D6F324Q35686137-3EAD50B8-A753-4FBE-8753-A2845F263839Q35741861-15696C9B-83E3-439C-9197-673CD75FAB8DQ35775750-5BA215F1-9A14-497C-B16E-50505D124DD6Q35857336-09968EB8-9F48-49D7-A2D3-5491D3B88CDFQ35858022-7DE185A0-00D1-4CC1-9FCA-B7A66E20D674Q35914342-4DCE99FB-CB27-475F-8450-3ED0C101CD2CQ35928311-38E8739B-0DD5-4429-8F3A-824CA1BE2106Q35993889-952B1DD8-84E4-476C-B0DC-189D6E07D525Q36001430-E50EB648-3F0F-4873-A1AA-CAE6F272C8E8Q36119183-7C2E03E6-BA4A-4656-B3C3-6205B6BEC7CF
P2860
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@ast
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@en
type
label
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@ast
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@en
prefLabel
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@ast
Human CD4(+) T lymphocytes con ...... r virus nuclear antigen EBNA1.
@en
P2093
P2860
P356
P1476
Human CD4(+) T lymphocytes con ...... rr virus nuclear antigen EBNA1
@en
P2093
A Chahroudi
K L Bickham
M G Kurilla
M Subklewe
R M Steinman
P2860
P304
P356
10.1084/JEM.191.10.1649
P407
P577
2000-05-01T00:00:00Z